Keyword Analysis & Research: remdesivir ebola kidney failure


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
remdesivir ebola kidney failure1.8158772531
remdesivir0.470.129116310
ebola1.560.85290995
kidney0.510.31053236
failure0.90.32116107

Keyword Research: People who searched remdesivir ebola kidney failure also searched

Keyword CPC PCC Volume Score
remdesivir ebola kidney failure1.080.6100412

Search Results related to remdesivir ebola kidney failure on Search Engine

  • Remdesivir: A Review of Its Discovery and Development Leading …

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202249/

    May 27, 2020 · As such, remdesivir was included in a randomized, controlled trial of Ebola virus therapeutics in patients within the Democratic Republic of the Congo (NCT02818582); however, midstudy primary analyses found remdesivir inferior to the antibody based therapeutics MAb114 and REGN-EB3, with respect to mortality, and the remdesivir intervention arm ...

    DA: 54 PA: 37 MOZ Rank: 27

  • Remdesivir in COVID-19: A critical review of pharmacology, pre …

    nih.gov

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214279/

    May 12, 2020 · Remdesivir is a broad spectrum anti-viral drug that has shown to ... Ebola virus (EBOV), Middle East respiratory syndrome (MERS-CoV), and Severe Acute respiratory ... Serious adverse events (acute kidney injury, septic shock, multi-organ failure) was noted in 23%, while 60% had at least one adverse event and 8% discontinued due to ...

    DA: 40 PA: 69 MOZ Rank: 74

  • First Degree Murder: Remdesivir is Being Used to 'Kill Us'

    rairfoundation.com

    https://rairfoundation.com/first-degree-murder-remdesivir-is-being-used-to-kill-us/

    Jan 29, 2022 · Dr. Anthony Fauci advocated for Remdesivir therapy in April of 2020. In his own citation of the Gilead study, 53 people from the US, Canada, Europe, and Japan, reported 60% adverse events – from renal failure to liver problems to multiple organ failure. The NIH even now warns about renal failure and liver toxicity from Remdesivir.

    DA: 83 PA: 61 MOZ Rank: 32

  • FDA Approves Remdesivir for Babies and Young Children to Treat …

    needtoknow.news

    https://needtoknow.news/2022/04/fda-approves-remdesivir-for-babies-and-young-children-to-treat-covid-19/

    Apr 29, 2022 · Reports show that Remdesivir causes severe side effects that includean dysfunction, septic shock and kidney and liver damage. While other COVID-19 treatments have received emergency use authorization for children younger than 12, Remdesivir, marketed under the name Veklury by Gilead Sciences, is the first to receive full FDA approval.

    DA: 8 PA: 29 MOZ Rank: 58

  • FDA Approves Killer COVID Drug for Babies - Health Impact News

    healthimpactnews.com

    https://healthimpactnews.com/2022/fda-approves-killer-covid-drug-for-babies/

    May 05, 2022 · A variety of problems can arise secondary its use, including liver inflammation, renal insufficiency and renal failure. Here is a list of articles revealing its kidney toxicity: https://pubmed.ncbi.nlm.nih.gov/33340409/ WHO recommended against the drug on November 20, 2020. Few if any other countries used it for COVID apart from the US.

    DA: 59 PA: 57 MOZ Rank: 56

  • Severe Covid-19 | NEJM

    nejm.org

    https://www.nejm.org/doi/full/10.1056/NEJMcp2009575

    May 15, 2020 · Data from a randomized, placebo-controlled trial involving more than 1000 patients with severe Covid-19 showed that the antiviral agent remdesivir reduced time to clinical recovery; the benefit ...

    DA: 83 PA: 31 MOZ Rank: 92

  • Clinical Spectrum | COVID-19 Treatment Guidelines

    nih.gov

    https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/

    Oct 19, 2021 · Patients with SARS-CoV-2 infection can experience a range of clinical manifestations, from no symptoms to critical illness. In general, adults with SARS-CoV-2 infection can be grouped into the following severity of illness categories; however, the criteria for each category may overlap or vary across clinical guidelines and clinical trials, and a patient’s …

    DA: 48 PA: 21 MOZ Rank: 55

  • Journal of Pharmacy Technology: SAGE Journals

    sagepub.com

    https://journals.sagepub.com/home/pmt

    Jun 13, 2022 · About this journal. For both pharmacists and technicians, Journal of Pharmacy Technology provides valuable peer-reviewed information for those interested in the entire body of pharmacy practice. The Journal of Pharmacy Technology covers new drugs, products, and equipment; therapeutic trends; organizational, legal, and educational activities; and drug …

    DA: 57 PA: 87 MOZ Rank: 78

  • SAHPRA today revoked permission for Ivermectin to be used to …

    lovinglifetv.com

    https://lovinglifetv.com/sahpra-today-revoked-permission-for-ivermectin-to-be-used-to-treat-covid-19-reflecting-their-compromised-position-with-big-pharma/

    May 30, 2022 · Remdesivir seems to have been chosen from a group of products examined for the purpose, a group in which every other product was likely a better candidate than it was; in fact, Remdesivir was recalled as a failure in the treatment of Ebola, and offers some serious adverse effects, including kidney failure. ... Remdesivir was recalled as a ...

    DA: 25 PA: 34 MOZ Rank: 91

  • COVID-19 - Simple English Wikipedia, the free encyclopedia

    wikipedia.org

    https://simple.wikipedia.org/wiki/COVID-19

    Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus.. The disease is the cause of the COVID-19 pandemic. People who get the disease might get fever, dry cough, fatigue (tiredness), loss of taste or smell, and shortness of breath. A sore throat, runny nose, or sneezing is less common.

    DA: 41 PA: 6 MOZ Rank: 22